• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有高度免疫抑制特性的调节性T细胞在乳腺肿瘤微环境中的优先积累。

Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.

作者信息

Syed Khaja Azharuddin Sajid, Toor Salman M, El Salhat Haytham, Faour Issam, Ul Haq Navid, Ali Bassam R, Elkord Eyad

机构信息

Cancer Research Center, Qatar Biomedical Research Institute, College of Science and Engineering, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.

Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

出版信息

Oncotarget. 2017 May 16;8(20):33159-33171. doi: 10.18632/oncotarget.16565.

DOI:10.18632/oncotarget.16565
PMID:28388539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5464858/
Abstract

Immunosuppressive cells such as regulatory T cells (Tregs) have an ambiguous role in breast cancer prognosis, with studies reporting both positive and negative correlations between Treg infiltration and prognosis. This discrepancy could be due to the different immunosuppressive molecules present in these cells. In the present study, we phenotypically characterize different Treg subsets infiltrating the tumor microenvironment (TME), compared to adjacent normal tissue and peripheral blood of primary breast cancer (PBC) patients. We report that the majority of tumor-infiltrating CD4+ and CD8+ T cells have terminally exhaustive phenotype as assessed by CD39 and PD-1 expressions. We also show that Tregs are accumulated in breast TME compared to normal tissue. Further characterization of Tregs showed that these are mainly FoxP3+Helios+ and express high levels of CTLA-4 and PD-1. This preferential accumulation of FoxP3+Helios+ Treg subset with co-expression of different immune inhibitory molecules might have a negative effect on breast cancer prognosis. Taken together, our results suggest that breast tumor cells might utilize Tregs, and different suppressive pathways involving CD39, PD-1 and CTLA-4 molecules in creating an immune-subversive environment for them to survive, and a dual blockade of these immunosuppressive molecules might be considered as an effective method in breast cancer treatment.

摘要

免疫抑制细胞,如调节性T细胞(Tregs),在乳腺癌预后中具有模糊的作用,研究报告Treg浸润与预后之间存在正相关和负相关。这种差异可能是由于这些细胞中存在不同的免疫抑制分子。在本研究中,我们对浸润肿瘤微环境(TME)的不同Treg亚群进行了表型特征分析,并与原发性乳腺癌(PBC)患者的相邻正常组织和外周血进行了比较。我们报告说,通过CD39和PD-1表达评估,大多数肿瘤浸润性CD4+和CD8+ T细胞具有终末耗竭表型。我们还表明,与正常组织相比,Tregs在乳腺TME中积累。Tregs的进一步特征表明,这些主要是FoxP3+Helios+,并表达高水平的CTLA-4和PD-1。这种FoxP3+Helios+ Treg亚群的优先积累以及不同免疫抑制分子的共表达可能对乳腺癌预后产生负面影响。综上所述,我们的结果表明,乳腺肿瘤细胞可能利用Tregs以及涉及CD39、PD-1和CTLA-4分子的不同抑制途径来创造一个免疫颠覆环境以供它们生存,对这些免疫抑制分子的双重阻断可能被认为是乳腺癌治疗的有效方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/749f300d0d5a/oncotarget-08-33159-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/553386d5c125/oncotarget-08-33159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/8c7f00e97ec5/oncotarget-08-33159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/75e5fce9350a/oncotarget-08-33159-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/4e0f283aa7f8/oncotarget-08-33159-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/660e44eaab66/oncotarget-08-33159-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/6e32f494fa7d/oncotarget-08-33159-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/749f300d0d5a/oncotarget-08-33159-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/553386d5c125/oncotarget-08-33159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/8c7f00e97ec5/oncotarget-08-33159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/75e5fce9350a/oncotarget-08-33159-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/4e0f283aa7f8/oncotarget-08-33159-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/660e44eaab66/oncotarget-08-33159-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/6e32f494fa7d/oncotarget-08-33159-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/5464858/749f300d0d5a/oncotarget-08-33159-g007.jpg

相似文献

1
Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.具有高度免疫抑制特性的调节性T细胞在乳腺肿瘤微环境中的优先积累。
Oncotarget. 2017 May 16;8(20):33159-33171. doi: 10.18632/oncotarget.16565.
2
Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.肿瘤微环境决定调节性 T 细胞表型:上调的免疫检查点增强抑制功能。
J Immunother Cancer. 2019 Dec 4;7(1):339. doi: 10.1186/s40425-019-0785-8.
3
Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.浸润性淋巴细胞、肿瘤特征与早期乳腺癌患者复发。
Am J Clin Oncol. 2013 Jun;36(3):224-31. doi: 10.1097/COC.0b013e3182467d90.
4
Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中肿瘤相关T淋巴细胞亚群和免疫检查点分子的特征分析
Oncotarget. 2017 Jul 4;8(27):44418-44433. doi: 10.18632/oncotarget.17901.
5
Intratumoral FoxP3Helios Regulatory T Cells Upregulating Immunosuppressive Molecules Are Expanded in Human Colorectal Cancer.上调免疫抑制分子的肿瘤内FoxP3Helios调节性T细胞在人类结直肠癌中扩增。
Front Immunol. 2017 May 26;8:619. doi: 10.3389/fimmu.2017.00619. eCollection 2017.
6
Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.调节性 T 淋巴细胞浸润转移性乳腺癌-独立的预后因素,其随着肿瘤进展而变化。
Breast Cancer Res. 2021 Feb 18;23(1):27. doi: 10.1186/s13058-021-01403-0.
7
Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.肿瘤浸润调节性 T 细胞、髓系来源抑制细胞和吲哚胺 2,3-双加氧酶表达与乳腺癌新辅助化疗结局的关系。
Cancer Biol Ther. 2018 Aug 3;19(8):695-705. doi: 10.1080/15384047.2018.1450116. Epub 2018 May 8.
8
Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.乳腺癌患者不同阶段肿瘤浸润性T细胞的差异调控及功能
Tumour Biol. 2015 Sep;36(10):7907-13. doi: 10.1007/s13277-015-3507-y. Epub 2015 May 8.
9
Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.利用高维蛋白质组学和转录组学分析描绘肝细胞癌中的免疫抑制梯度。
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5900-E5909. doi: 10.1073/pnas.1706559114. Epub 2017 Jul 3.
10
Immune Checkpoints in Circulating and Tumor-Infiltrating CD4 T Cell Subsets in Colorectal Cancer Patients.结直肠癌患者循环和肿瘤浸润 CD4 T 细胞亚群中的免疫检查点。
Front Immunol. 2019 Dec 17;10:2936. doi: 10.3389/fimmu.2019.02936. eCollection 2019.

引用本文的文献

1
Nanotechnology-based shikonin delivery strategies for modulating the tumor immune microenvironment efficacy.基于纳米技术的紫草素递送策略对肿瘤免疫微环境功效的调节作用
Drug Deliv Transl Res. 2025 Aug 11. doi: 10.1007/s13346-025-01943-4.
2
Investigation of the CTLA-4-CD28 Axis in Oral Squamous Cell Carcinoma.口腔鳞状细胞癌中CTLA-4-CD28轴的研究
J Clin Med. 2025 Jul 21;14(14):5171. doi: 10.3390/jcm14145171.
3
Co-targeting of epigenetic regulators and BCL-XL improves efficacy of immune checkpoint blockade therapy in multiple solid tumors.

本文引用的文献

1
Myeloid cells in circulation and tumor microenvironment of breast cancer patients.乳腺癌患者循环系统和肿瘤微环境中的髓样细胞。
Cancer Immunol Immunother. 2017 Jun;66(6):753-764. doi: 10.1007/s00262-017-1977-z. Epub 2017 Mar 10.
2
Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer Patients.结直肠癌患者循环及肿瘤浸润粒细胞性髓样细胞水平升高。
Front Immunol. 2016 Dec 8;7:560. doi: 10.3389/fimmu.2016.00560. eCollection 2016.
3
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer.
对表观遗传调节因子和BCL-XL进行共同靶向可提高免疫检查点阻断疗法在多种实体瘤中的疗效。
Mol Cancer. 2025 May 30;24(1):154. doi: 10.1186/s12943-025-02352-4.
4
Expression of VISTA on T cells in patients with cancer colon.结肠癌患者T细胞上VISTA的表达。
J Egypt Natl Canc Inst. 2025 May 23;37(1):41. doi: 10.1186/s43046-025-00287-x.
5
The Role of Long Non-Coding RNAs in Modulating the Immune Microenvironment of Triple-Negative Breast Cancer: Mechanistic Insights and Therapeutic Potential.长链非编码RNA在调节三阴性乳腺癌免疫微环境中的作用:机制见解与治疗潜力
Biomolecules. 2025 Mar 20;15(3):454. doi: 10.3390/biom15030454.
6
The clinical potential of PDL-1 pathway and some related micro-RNAs as promising diagnostic markers for breast cancer.PDL-1通路及一些相关微小RNA作为乳腺癌有前景的诊断标志物的临床潜力。
Mol Med. 2025 Mar 19;31(1):106. doi: 10.1186/s10020-025-01137-1.
7
Targeting CDK4/6 in breast cancer.在乳腺癌中靶向细胞周期蛋白依赖性激酶4/6(CDK4/6)
Exp Mol Med. 2025 Feb;57(2):312-322. doi: 10.1038/s12276-025-01395-3. Epub 2025 Feb 10.
8
SHR-1806, a robust OX40 agonist to promote T cell-mediated antitumor immunity.SHR-1806,一种强效的 OX40 激动剂,可促进 T 细胞介导的抗肿瘤免疫。
Cancer Biol Ther. 2024 Dec 31;25(1):2426305. doi: 10.1080/15384047.2024.2426305. Epub 2024 Nov 14.
9
High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype.高CTLA-4基因表达是乳腺癌患者尤其是HER2富集亚型患者的独立良好预后因素。
Cancer Cell Int. 2024 Nov 10;24(1):371. doi: 10.1186/s12935-024-03554-4.
10
Impact of anti leukemia inhibitory factor antibody on immune related gene expression in breast cancer Balb/c mouse model.抗白血病抑制因子抗体对乳腺癌 Balb/c 小鼠模型免疫相关基因表达的影响。
Sci Rep. 2024 Sep 2;14(1):20403. doi: 10.1038/s41598-024-71014-0.
调节性T细胞在人类乳腺癌中表现出不同特征。
Immunity. 2016 Nov 15;45(5):1122-1134. doi: 10.1016/j.immuni.2016.10.032.
4
Clinical significance of tumor-infiltrating lymphocytes in breast cancer.乳腺癌肿瘤浸润淋巴细胞的临床意义。
J Immunother Cancer. 2016 Oct 18;4:59. doi: 10.1186/s40425-016-0165-6. eCollection 2016.
5
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting.肿瘤微环境中的调节性 T 细胞与癌症进展:作用和治疗靶点。
Vaccines (Basel). 2016 Aug 6;4(3):28. doi: 10.3390/vaccines4030028.
6
The role of regulatory T cells in cancer immunology.调节性T细胞在癌症免疫学中的作用。
Immunotargets Ther. 2015 Aug 5;4:159-71. doi: 10.2147/ITT.S55415. eCollection 2015.
7
Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.两种 FOXP3(+)CD4(+) T 细胞亚群可明显控制结直肠癌的预后。
Nat Med. 2016 Jun;22(6):679-84. doi: 10.1038/nm.4086. Epub 2016 Apr 25.
8
Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.将FoxP3和Helios与GARP/LAP标志物相结合,能够识别癌症患者中扩增的调节性T细胞亚群。
Oncotarget. 2016 Mar 22;7(12):14083-94. doi: 10.18632/oncotarget.7334.
9
Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals.活化T细胞上CD39的表达会损害其在老年人中的存活。
Cell Rep. 2016 Feb 9;14(5):1218-1231. doi: 10.1016/j.celrep.2016.01.002. Epub 2016 Jan 28.
10
Targeting regulatory T cells in tumors.靶向肿瘤中的调节性T细胞。
FEBS J. 2016 Jul;283(14):2731-48. doi: 10.1111/febs.13656. Epub 2016 Mar 1.